SEC Form 4 · accession 0001209191-17-001981
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey E Young
Officer — Chief Financial Officer
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonqualified Stock Option (right to buy)F1,F2 | $5.60 | Jan 3, 2017 | A | 170,000 | A | — | Jan 3, 2024 | Common Stock | 170,000 | 170,000 | D |
Explanation of responses
- F1This stock option is an inducement grant made pursuant to NASDAQ Stock Market Rule 5635(c).
- F2The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.